Gene: SCYGR5
Official Full Name: small cysteine and glycine repeat containing 5provided by HGNC
Gene Summary: Predicted to be located in intermediate filament. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14289 | SCYGR5 Knockout cell line (HeLa) | Human | SCYGR5 | 1:3~1:6 | Negative | Online Inquiry |
KO14290 | SCYGR5 Knockout cell line (HCT 116) | Human | SCYGR5 | 1:2~1:4 | Negative | Online Inquiry |
KO14291 | SCYGR5 Knockout cell line (A549) | Human | SCYGR5 | 1:3~1:4 | Negative | Online Inquiry |
SCYGR5 Gene Knockout Cell Lines are genetically engineered cellular models created to explore the functional role of the SCYGR5 gene across various biological contexts. This innovative product utilizes advanced CRISPR-Cas9 technology to induce targeted deletions in the SCYGR5 gene, leading to a complete loss of gene expression. By providing researchers with a reliable and reproducible cellular platform, these knockout cell lines facilitate comprehensive studies into the gene’s involvement in critical cellular processes such as signal transduction, differentiation, and disease pathology.
The primary function of SCYGR5 Gene Knockout Cell Lines lies in their ability to elucidate the physiological and pathological roles of the SCYGR5 gene in vitro. The gene knockout allows for an examination of resultant phenotypic changes, offering insights into gene function through comparative analyses with wild-type cell lines. This mechanism is invaluable for researchers endeavoring to uncover the molecular underpinnings of various conditions, including cancer, neurodegenerative diseases, and metabolic disorders.
Scientifically, the SCYGR5 knockout cell lines represent a crucial tool in both academic and clinical research settings. These models can enhance the understanding of gene-gene interactions and potential therapeutic targets, paving the way for novel treatment strategies. Furthermore, they are instrumental in drug discovery, enabling high-throughput screening for therapeutic compounds that can modulate SCYGR5-related pathways.
One of the key advantages of SCYGR5 Gene Knockout Cell Lines is their specificity and ease of use. Unlike traditional knockout methods, which often result in off-target effects or mosaicism, our cell lines provide precise gene disruptions that ensure more reliable experimental outcomes. Additionally, our stringent quality control measures guarantee consistent performance across batches, which is critical for reproducibility in research.
Researchers and clinicians stand to benefit significantly from incorporating these cell lines into their studies, potentially accelerating the pace of discovery and ensuring that results are both interpretive and relevant to human health. As a company dedicated to advancing biological research tools, we leverage our extensive expertise in molecular genetics and cell biology to deliver high-quality knockout models that empower scientists to explore the complexities of gene function with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.